Wendell H. Rooks
Worcester Foundation for Biomedical Research
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Wendell H. Rooks.
Fertility and Sterility | 1968
Wendell H. Rooks; Sheldon L. Kugler; Ralph I. Dorfman
Total effective estrogenicity of several human oral contraceptives was investigated through a method determining uterine weight in immature rats. The preparations, normally given to human females in tablet, form were Norinyl-1 (.05 mg mestranol, 1mg norethindrone), Norinyl-2 (.10 mg mestranol, 2 mg norethindrone), Ovulen (.10 mg mestranol, 1mg ethynodiol diacetate), Enovid-E (.10 mg mestranol, 2.5 mg norethynodrel), and Enovid-5 (.075 mg mestranol, 5mg norethynodrel). Each products was administered in total doses of .0025, .005, and .01 of a tablet. Each dose had 3 trials, approximately 10 mice to a trial. Each mouse was given the compound in .2 ml aqueous vehicle orally, daily for a 3-day period so that the sum of the daily doses equaled 1 of the tablet fractions above. Autopsy, on Day 4, discovered the ratio of mg uterus/gm body weight. A .0025 fraction of a tablet of Norinyl-1 produced a mean uterine ratio of 1.79, while control (untreated) mice had a mean ratio of 1.06. Norinyl-2, Ovulen, Enovid-5 and Enovid-E, judging from the corresponding increases in ratios from the control ratio, were found to be 2.1, 2.7, 6, and 8 times, respectively, more estrogenic than Norinyl-1. The relatively high estrogenicity of the Enovids is probably due to the conversion of norethynodrel to estrogenic compounds.
Surgery Today | 1973
Satoshi Yoshizaki; Wendell H. Rooks; Ralph I. Dorfman
Paw necrosis in the adrenalectomized rat was induced by severing the common iliac or ligating the femoral blood vessels. Necrosis did not appear in non-adrenalectomized animals. Administration of either hydrocortisone, 6α, 9α-Difluoro-11β, 16α, 17α, 21-tetrahydroxy-pregna-1, 4-diene-3, 20-dione 16, 17-acetonide or 9α, 11β-dichloro-6α-fluoro-16α, 17α, 21-trihydroxy-pregna-1, 4-diene-3, 20-dione 16, 17-acetonide directly into the paw within two hours after vascular impairment prevented the paw necrosis.
Experimental Biology and Medicine | 1971
Wendell H. Rooks; Elizabeth Lloyd; Ralph I. Dorfman
Summary NMB was given in one subcutaneous injection in oil at a dose of 6 mg to female rats on nitrogen and body weight balance. A constant level of food was consumed. A highly significant and prolonged nitrogen retention was obtained. No nitrogen excretion rebound was seen. A significant increase in body weight was produced which was maintained for 19 weeks.
Journal of Medicinal Chemistry | 1970
Ian T. Harrison; Brian. Lewis; Peter H. Nelson; Wendell H. Rooks; Adolph P. Roszkowski; Albert J. Tomolonis; John H. Fried
Journal of Pharmacology and Experimental Therapeutics | 1971
Adolph P. Roszkowski; Wendell H. Rooks; Albert J. Tomolonis; Lois M. Miller
Journal of Medicinal Chemistry | 1978
Juerg R. Pfister; Rodolfo W. Ferraresi; Ian T. Harrison; Wendell H. Rooks; John H. Fried
Endocrinology | 1961
Wendell H. Rooks; Ralph I. Dorfman
Journal of Medicinal Chemistry | 1966
Ralph I. Dorfman; Wendell H. Rooks; J. Bryan Jones; Jeffrey D. Leman
Chemotherapy | 1963
Wendell H. Rooks; Tanekazu Harada; Osahiko Abe; Ralph I. Dorfman
Journal of Medicinal Chemistry | 1968
Ian T. Harrison; C. Beard; L. Kirkham; B. Lewis; I. M. Jamieson; Wendell H. Rooks; John H. Fried